Skip to main content
Veterinary Medicines

VITAMIVET K1 50 MG FILM-COATED TABLETS FOR DOGS

Authorised
  • Phytomenadione

Product identification

Medicine name:
VITAMIVET K1 50 MG FILM-COATED TABLETS FOR DOGS
VITAMIVET K1 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA PARA PERROS
Active substance:
  • Phytomenadione
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phytomenadione
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB02BA01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2732 ESP
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0208/002
Concerned member states:
  • Austria
  • Germany
  • Italy
  • Netherlands
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 22/05/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 22/02/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 23/05/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."